Nuclear Medicine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Nuclear Medicine Market Growth and it is Segmented by Product Type (Diagnostics (Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET)) and Therapeutics (Alpha Emitters, Beta Emitters, and Brachytherapy)), and by Applications (Cardiology, Neurology, Oncology, and Other Applications) and Geography (North America, Europe, Asia Pacific, Middle East, and Africa, and South America). The market size and forecasts are provided in terms of value (in USD million) for the above segments.

Nuclear Medicine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Nuclear Medicine Industry Overview

The studied market is moderately fragmented. There is high competition among the players in the global nuclear medicine market. However, this competition is not by competitive pricing or product differentiation. Additionally, big players in the pharmaceutical and biotechnology industries are leveraging their huge capital reserves to venture into this market, which is further increasing the competition. Major players in the market include GE Healthcare, Lantheus Medical Imaging, Advanced Accelerator Programs, Cardinal Health Inc., and Curium, among others.

Nuclear Medicine Market Leaders

  1. GE Healthcare

  2. Curium Pharma

  3. Novartis (Advanced Accelerator Applications)

  4. Cardinal Health

  5. Lantheus Medical Imaging

  6. *Disclaimer: Major Players sorted in no particular order
Nuclear Medicine Market Concentration